VCM
HRMY icon

Versant Capital Management’s Harmony Biosciences HRMY Stock Holding History

Versant Capital Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.3K Buy
364
+343
+1,633% +$10.8K ﹤0.01% 2133
2026
Q1 		$588 Buy
21
+6
+40% +$197 ﹤0.01% 2710
2025
Q4 		$561 Sell
15
-336
-96% -$11K ﹤0.01% 2578
2025
Q3 		$9.67K Buy
351
+100
+40% +$3.44K ﹤0.01% 1953
2025
Q2 		$7.93K Buy
251
+96
+62% +$3.09K ﹤0.01% 1989
2025
Q1 		$5.14K Hold
155
– – ﹤0.01% 2018
2024
Q4 		$5.33K Buy
155
+140
+933% +$4.81K ﹤0.01% 1724
2024
Q3 		$600 Hold
15
– – ﹤0.01% 1840
2024
Q2 		$453 Hold
15
– – ﹤0.01% 1806
2024
Q1 		$504 Hold
15
– – ﹤0.01% 1689
2023
Q4 		$485 Sell
15
-7
-32% -$195 ﹤0.01% 1688
2023
Q3 		$721 Hold
22
– – ﹤0.01% 1622
2023
Q2 		$774 Hold
22
– – ﹤0.01% 1690
2023
Q1 		$719 Sell
22
-44
-67% -$2K ﹤0.01% 1525
2022
Q4 		$3.64K Hold
66
– – ﹤0.01% 986
2022
Q3 		$3K Buy
66
+44
+200% +$2.15K ﹤0.01% 983
2022
Q2 		$1K Buy
+22
New +$990 ﹤0.01% 1267

Other funds holding HRMY

CI
CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
P
Paradiem Covington, Louisiana $464M AUM 45.56% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Versant Capital Management's HRMY Position: Q2 2026 in Review

Versant Capital Management increased its Harmony Biosciences (HRMY) stake by 1,633% in Q2 2026, buying an estimated $10.8K and bringing the position to 364 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2133.

Versant Capital Management first reported a position in HRMY in Q2 2022 and has held it in 17 quarters since. 35 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Versant Capital Management held 364 shares of Harmony Biosciences worth $13.3K as of Q2 2026.
  • Versant Capital Management bought 343 Harmony Biosciences shares in Q2 2026, an estimated $10.8K.
  • Harmony Biosciences made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2133 holding.
  • Versant Capital Management first reported a position in Harmony Biosciences in Q2 2022 and has held it in 17 quarters since.
  • 35 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.